Quick Takeaways
- Margaret Olinger has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $5,178,792.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Margaret Olinger
- Location
- Cambridge, MA
- Summary
- The estimated net worth of Margaret Olinger is at least $5,178,792 dollars as of 29 Dec 2023. Margaret Olinger is the Chief Commercial Officer of Amylyx Pharmaceuticals, Inc. and owns shares of Amylyx Pharmaceuticals, Inc. (AMLX) stock worth about $5.18M.
- Signature
- /s/ Joshua B. Cohen, as Attorney in Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Margaret Olinger and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Amylyx Pharmaceuticals, Inc. ($5,178,792).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Margaret Olinger
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | Chief Commercial Officer | $5,178,792 | 27 Dec 2023 |
Insider Transactions Reported by Margaret Olinger:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.